| Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial T Karampitsakos, O Papaioannou, P Tsiri, M Katsaras, A Katsimpris, ... Clinical Microbiology and Infection 29 (3), 372-378, 2023 | 31 | 2023 |
| Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study T Karampitsakos, E Malakounidou, O Papaioannou, V Dimakopoulou, ... Respiratory research 22 (1), 317, 2021 | 14 | 2021 |
| Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model T Karampitsakos, V Sotiropoulou, M Katsaras, P Tsiri, ... Frontiers in medicine 9, 1083264, 2023 | 10 | 2023 |
| Safety and effectiveness of mycophenolate mofetil in interstitial lung diseases: insights from a machine learning radiographic model T Karampitsakos, C Kalogeropoulou, V Tzilas, O Papaioannou, ... Respiration 101 (3), 262-271, 2022 | 8 | 2022 |
| High-flow vs. low-flow nasal cannula in reducing hypoxemic events during bronchoscopic procedures: a systematic review and meta-analysis F Sampsonas, V Karamouzos, T Karampitsakos, O Papaioannou, ... Frontiers in Medicine 9, 815799, 2022 | 8 | 2022 |
| Clinical features and outcomes of patients with myositis associated-interstitial lung disease T Karampitsakos, V Tzilas, O Papaioannou, S Chrysikos, E Vasarmidi, ... Frontiers in Medicine 9, 1096203, 2023 | 7 | 2023 |
| Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis. O Papaioannou, T Karampitsakos, P Tsiri, V Sotiropoulou, E Koulousousa, ... European Review for Medical & Pharmacological Sciences 26 (20), 2022 | 4 | 2022 |
| CTPA imaging findings, beyond pulmonary embolism, in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection and their relation to clinical outcome-a single … F Sampsonas, M Lagadinou, C Kalogeropoulou, V Karamouzos, ... European Review for Medical & Pharmacological Sciences 26 (12), 2022 | 3 | 2022 |
| Elevated peripheral blood monocyte count is associated with prolonged postoperative hospitalization and functional decline in patients with interstitial lung diseases … T Karampitsakos, T Milas, P Tsiri, M Katsaras, E Koletsis, K Vachlas, ... European review for medical and pharmacological sciences 28 (10), 3683-3696, 2024 | | 2024 |
| Corrigendum: Post-COVID-interstitial lung disease: Insights from a machine learning radiographic model A Tzouvelekis, T Karampitsakos, V Sotiropoulou, M Katsaras, P Tsiri, ... Immune-Mediated Lung Injury, 89, 2023 | | 2023 |
| Pulmonary embolism and abdominal pain in a young patient: A case report of a rare clinical entity. F Sampsonas, P Tsiri, V Sotiropoulou, G Tsirikos, M Katsaras, ... Pneumon 36 (4), 2023 | | 2023 |
| Drug-induced interstitial lung disease: insights from a referral center V Sotiropoulou, P Tsiri, T Karampitsakos, M Katsaras, O Papaioannou, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| EBUS-TBNA in octogenarians: Diagnostic yield, sedation and safety. An 8 month, single center, experience F Sampsonas, G Tsirikos, M Katsaras, T Karampitsakos, O Papaioannou, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Biologic agents in idiopathic hypereosinophilic syndrome: a case series O Papaioannou, T Karampitsakos, E Zarkadi, P Tsiri, E Koulousousa, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Intrapleural instillation of r-tPA in complicated parapneumonic effusion or empyema: a single center experience O Papaioannou, E Koulousousa, T Karampitsakos, P Tsiri, G Tsirikos, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Lower respiratory tract infections treatment recommendations: An overview. E Malakounidou, P Tsiri, E Theohari, E Koulousousa, T Karampitsakos, ... Pneumon 36 (3), 2023 | | 2023 |
| Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model T Karampitsakos, V Sotiropoulou, M Katsaras, P Tsiri, ... Frontiers in medicine 10, 1194925, 2023 | | 2023 |
| Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial.(preprint) T Karampitsakos, O Papaioannou, P Tsiri, M Katsaras, A Katsimpris, ... | | 2022 |
| Tocilizumab in hospitalized patients with severe COVID-19: an open label, prospective study T Karampitsakos, E Malakounidou, O Papaioannou, V Dimakopoulou, ... | | 2021 |
| Safety and effectiveness of mycophenolate mofetil in interstitial lung diseases T Karampitsakos, V Tzilas, O Papaioannou, E Koukaki, M Katsaras, ... European Respiratory Journal 58 (suppl 65), 2021 | | 2021 |
